scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1368-5031.2004.00295.X |
P698 | PubMed publication ID | 15587768 |
P2093 | author name string | Jones M | |
Loftus J | |||
Savani N | |||
Landy S | |||
Shackelford S | |||
P2860 | cites work | Is menstrually associated migraine difficult to treat? | Q33754145 |
P433 | issue | 10 | |
P921 | main subject | migraine | Q133823 |
menstruation | Q12171 | ||
P304 | page(s) | 913-919 | |
P577 | publication date | 2004-10-01 | |
P1433 | published in | International Journal of Clinical Practice | Q15758177 |
P1476 | title | Efficacy and tolerability of sumatriptan tablets administered during the mild-pain phase of menstrually associated migraine | |
P478 | volume | 58 |
Q36638660 | A review of the use of frovatriptan in the treatment of menstrually related migraine |
Q37897224 | Almotriptan for menstrually related migraine |
Q37798757 | Are the current IHS guidelines for migraine drug trials being followed? |
Q38927015 | Comparative tolerability of treatments for acute migraine: A network meta-analysis |
Q45995793 | Comparing the efficacy of eletriptan for migraine in women during menstrual and non-menstrual time periods: a pooled analysis of randomized controlled trials. |
Q35522772 | Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan. |
Q34890784 | Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, multicenter, Italian, comparative study versus zolmitriptan |
Q46898774 | Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies. |
Q64113943 | From investigational product to active reference: evolution of oral sumatriptan efficacy versus placebo for the treatment of acute migraine episodes and potential impact in comparative analyses |
Q36052155 | Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study |
Q37785552 | Influence of trigger factors on the efficacy of almotriptan as early intervention for the treatment of acute migraine in a primary care setting: the START study |
Q34338801 | Management of menstrual migraine: a review of current abortive and prophylactic therapies |
Q85056313 | Menstrual and nonmenstrual migraines differ in women with menstrually-related migraine |
Q50047547 | Menstrual migraine: a review of current and developing pharmacotherapies for women |
Q38237616 | Menstrual migraine: an updated review on hormonal causes, prophylaxis and treatment |
Q36941893 | Menstrual migraine: clinical and therapeutical aspects |
Q36153372 | Migraine treatment throughout the lifecycle |
Q37363486 | Perimenstrual headache: treatment options |
Q34623397 | Prevention and Treatment of Menstrual Migraine |
Q39336473 | Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies |
Q43265529 | Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks |
Q39284852 | Sumatriptan (50 mg tablets vs. 25 mg suppositories) in the acute treatment of menstrually related migraine and oral contraceptive-induced menstrual migraine: a pilot study |
Q24203707 | Sumatriptan (oral route of administration) for acute migraine attacks in adults |
Q38066258 | Sumatriptan: a review of its pharmacokinetics, pharmacodynamics and efficacy in the acute treatment of migraine |
Q36305785 | The use of triptans in the management of menstrual migraine |
Q39277602 | Total migraine freedom, a potential primary endpoint to assess acute treatment in migraine: comparison to the current FDA requirement using the complete rizatriptan study database. |
Q38014363 | Treatment of perimenstrual migraine with triptans: an update |
Q37248355 | Treatment satisfaction and efficacy of the rapid release formulation of sumatriptan 100 mg tablets utilising an early intervention paradigm in patients previously unsatisfied with sumatriptan |
Q51314345 | Treatment strategies for menstrually related migraine. |
Q35692944 | Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis |
Q46955158 | Triptans in the treatment of migraine: drug selection by means of the SOJA method |
Search more.